ATACs: A New Payload Provides New Options for Cancer Therapy
Time: 4:00 pm
day: Day Two PM
Details:
- Discussing a payload with a new mode of action providing new options to fight cancer
- Understanding how the ATAC platform optimized the ADC technology for that unique payload
- Clinical update on HDP-101 targeting BCMA; the first ATAC which is now in dose escalation in myeloma patients
